ATP2C2-WFDC1 Fusion FISH Probe
The ATP2C2-WFDC1 Fusion FISH Probe is used to confirm a fusion of the ATP2C2 and WFDC1 genes. The fusion of the ATP2C2 and WFDC1 genes has been associated with Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ATP2C2-WFDC1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ATP2C2-WFDC1-20-AQAQ | 20 (40 μL) | 200 μL |
|
ATP2C2 Gene Summary
The ATPase Secretory Pathway Ca2+ Transporting 2 (ATP2C2) gene is located on chr16 :84402132-84497793 at 16q24.1.
Gene Name: ATPase Secretory Pathway Ca2+ Transporting 2
Chromosome: CHR16: 84402132 -84497793
Locus: 16q24.1
WFDC1 Gene Summary
This gene encodes a member of the WAP-type four disulfide core domain family. The WAP-type four-disulfide core domain contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor in many family members. This gene is mapped to chromosome 16q24, an area of frequent loss of heterozygosity in cancers, including prostate, breast and hepatocellular cancers and Wilms' tumor. This gene is downregulated in many cancer types and may be involved in the inhibition of cell proliferation. The encoded protein may also play a role in the susceptibility of certain CD4 memory T cells to human immunodeficiency virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Gene Name: WAP Four-disulfide Core Domain 1
Chromosome: CHR16: 84328400 -84363450
Locus: 16q24.1
Gene Diseases
The ATP2C2 WFDC1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|